Genmab As Stock Price Patterns

Intrinsic Valuation Low Real High 28.71 34.96 37.24 Details

Naive Forecast Low Next High 29.37 31.66 33.94 Details

9 Analysts Consensus Low Target High 34.64 38.07 42.26 Details

Earnings Estimates (0) Low Projected EPS High 0.46 0.42 0.50 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genmab AS. Your research has to be compared to or analyzed against Genmab AS's peers to derive any actionable benefits. When done correctly, Genmab AS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genmab AS.

Genmab AS After-Hype Price Density Analysis

Genmab AS Estimiated After-Hype Price Volatility

Genmab AS Stock Price Outlook Analysis

Notes

Genmab AS Hype Timeline

Genmab AS is currently traded for 31.32. The entity has historical hype elasticity of -0.38, and average elasticity to hype of competition of 0.03. Genmab is forecasted to decline in value after the next headline, with the price expected to drop to 31.52. The average volatility of media hype impact on the company price is about 121.28%. The price decrease on the next news is expected to be -1.19%, whereas the daily expected return is currently at 0.2%. The volatility of related hype on Genmab AS is about 1433.96%, with the expected price after the next announcement by competition of 31.35. The book value of the company was currently reported as 93.41. The company has Price/Earnings To Growth (PEG) ratio of 0.64. Genmab AS had not issued any dividends in recent years. The entity had 5:1 split on the 1st of May 2018. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days. Check out Genmab AS Basic Forecasting Models to cross-verify your projections. For information on how to trade Genmab Stock refer to our How to Trade Genmab Stock guide.

Genmab AS Related Hype Analysis

Genmab AS Additional Predictive Modules

Most predictive techniques to examine Genmab price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Genmab using various technical indicators. When you analyze Genmab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Genmab AS stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Genmab AS, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Genmab AS based on analysis of Genmab AS hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.